These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 765024)

  • 1. Immunosuppression with cyclophosphamide in the dog.
    Putnam CW; Halgrimson CG; Groth CG; Kashiwagi N; Porter KA; Starzl TE
    Clin Exp Immunol; 1975 Nov; 22(2):323-9. PubMed ID: 765024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of donor pretreatment and low-dose immunosuppression on the 24-hour preserved canine renal allograft.
    Swistel AJ; McCabe RE; Lorieo DR; Wildstein A; Fitzpatrick HF
    Transplant Proc; 1979 Sep; 11(3):1673-5. PubMed ID: 388773
    [No Abstract]   [Full Text] [Related]  

  • 3. The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat.
    Winearls CG; Fabre JW; Millard PR; Morris PJ
    Clin Exp Immunol; 1979 Feb; 35(2):242-9. PubMed ID: 373937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of the immunosuppressive action of azathioprine and cyclophosphamide in experimental homologous liver transplant].
    da Cunha JE; Machado MC; Bacchella T; Margarido NF; Lima-Gonçalves E
    Rev Hosp Clin Fac Med Sao Paulo; 1977 Jun; 32(3):166-9. PubMed ID: 341264
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cyclophosphamide in renal transplantation].
    Guerra C; Andreu J; Tinaut J; Masaramón J; Lloveras J
    Actas Urol Esp; 1977; 1(4):195-200. PubMed ID: 354338
    [No Abstract]   [Full Text] [Related]  

  • 6. The enhancing effect of donor pretreatment and low dose immunosuppression in dogs.
    Swistel AJ; McCabe RE; Lorieo DR; Wildstein A; Pierce JC; Fitzpatrick HF
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():93-5. PubMed ID: 386328
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppression and clinical organ transplantation.
    Calne RY
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):49-51. PubMed ID: 4612904
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppression with cyclophosphamide in dogs following cardiac transplantation.
    Caves PK; Dong E; Shumway NE
    Transplant Proc; 1973 Mar; 5(1):517-21. PubMed ID: 4121177
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced antibody production by grafted peripheral blood immunocytes in cyclophosphamide-treated allogeneic chick embryo hosts.
    Seto F
    Exp Hematol; 1974; 2(4):219-26. PubMed ID: 4477078
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibition of antibody formation in sensitized animals. II. Comparison of cyclophosphamide and azathioprine in antigen-cystostatic combination therapy].
    Herrlinger JD; Müller-Ruchholtz W
    Verh Dtsch Ges Inn Med; 1974; 80():1599-601. PubMed ID: 4454492
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy of bolus doses of intravenous methylprednisolone (MPIV) in the treatment of acute renal allograft rejection.
    Kountz SL; Rao TK; Butt KH
    Transplant Proc; 1975 Mar; 7(1):73-7. PubMed ID: 1091048
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
    Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
    [No Abstract]   [Full Text] [Related]  

  • 13. Corticosteroids in immunosuppression: partial fulfillment of a promise.
    Friedman EA
    Transplant Proc; 1975 Mar; 7(1):1-3. PubMed ID: 164066
    [No Abstract]   [Full Text] [Related]  

  • 14. A contribution to the mechanism of drug inhibition of the graft vs host reaction.
    Levy L
    J Reticuloendothel Soc; 1973 Jan; 13(1):1-6. PubMed ID: 4144675
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclophosphamide in cardiac transplant recipients with frequent rejection: a six-year retrospective review.
    Wagoner LE; Taylor DO; Olsen SL; Bristow MR; O'Connell JB; Hammond EH; Lappe DL; Renlund DG
    Clin Transplant; 1996 Oct; 10(5):437-43. PubMed ID: 8930458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic immunosuppression.
    Salaman JR
    Transplant Proc; 1981 Mar; 13(1 Pt 1):311-4. PubMed ID: 7022842
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved immunosuppression for heart transplantation.
    Bolman RM; Elick B; Olivari MT; Ring WS; Arentzen CE
    J Heart Transplant; 1985 May; 4(3):315-8. PubMed ID: 3916502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective prevention of interstitial rejection crises in immunological high risk patients following renal transplantation: use of high doses of the new monoclonal antibody BMA 031.
    Dendorfer U; Hillebrand G; Kasper C; Smely S; Weschka M; Hammer C; Racenberg J; Gurland HJ; Land W
    Transplant Proc; 1990 Aug; 22(4):1789-90. PubMed ID: 2389450
    [No Abstract]   [Full Text] [Related]  

  • 19. Skin and renal rabbit allograft rejection following large pulse doses of methylprednisolone.
    Friedman EA; Beyer MM
    Transplant Proc; 1975 Mar; 7(1):67-72. PubMed ID: 1091047
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of humoral rejection after heart transplantation.
    Grauhan O; Müller J; v Baeyer H; Volk HD; Fietze E; Cohnert T; Meyer R; Pfitzmann R; Mansfeld H; Siniawski H; Warnecke H; Hetzer R
    J Heart Lung Transplant; 1998 Dec; 17(12):1184-94. PubMed ID: 9883759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.